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†German Cancer Research Center, BioQuant, Heidelberg, Germany; and ‡Max-Planck Institute for Intelligent Systems, Stuttgart, GermanyABSTRACT Based on their membrane-permeabilizing activity in vitro, it has been proposed that Bax-like proteins induce cyto-
chrome c release during apoptosis via pore formation. However, antiapoptotic Bcl-2 proteins, which inhibit cytochrome c release,
also display pore activity in model membranes. As a consequence, a unified description that aligns the pore activity of the Bcl-2
proteins with their apoptotic function is missing. Here, we studied the mechanism of membrane binding, oligomerization, and
permeabilization by pro- and antiapoptotic Bcl-2 members at the single-vesicle level. We found that proapoptotic Bax forms
large, stable pores via an all-or-none mechanism that can release cytochrome c. In contrast, antiapoptotic Bcl-xL induces tran-
sient permeability alterations in pure lipid membranes that have no consequences for the mitochondrial outer membrane but
inhibit Bax membrane insertion. These differences in pore activity correlate with a distinct oligomeric state of Bax and Bcl-xL
in membranes and can be reproduced in isolated mitochondria. Based on our findings, we propose new models for the mech-
anisms of action of Bax and Bcl-xL that relate their membrane activity to their opposing roles in apoptosis and beyond.INTRODUCTIONThe members of the Bcl-2 family are multifunctional
proteins. They are major regulators of apoptosis, and they
have recently also been associated with a number of addi-
tional roles, including the regulation of mitochondrial
energy metabolism and dynamics, cellular Ca2þ homeo-
stasis, autophagy, and the unfolded protein response at
the endoplasmic reticulum (ER) (1). Bcl-2 homologs,
including Bid, Bax, and Bcl-xL, have very similar cytosolic
folds and share the rare ability to switch from water-soluble
to membrane-inserted conformations. Indeed, most func-
tions of the Bcl-2 proteins are performed when associated
with cellular membranes, but the molecular mechanisms
involved remain unclear. For this reason, understanding
how the Bcl-2 proteins behave in lipid membranes is crucial
to identifying the molecular mechanisms behind their bio-
logical functions.
Currently, the regulation of apoptosis by the Bcl-2 proteins
is their best-characterized function. Bax and Bak induce per-
meabilization of the mitochondrial outer membrane (MOM)
that releases cytochrome c (cyt c) during apoptosis (2). They
are activated by some BH3 proteins like Bid and inhibited by
the antiapoptotic Bcl-2 proteins, like Bcl-xL. Despite intense
research, the mechanism of Bax-induced MOM permeabili-
zation remains controversial. During apoptosis Bax translo-
cates to the mitochondria and undergoes a conformational
change (3). This leads to its extensive insertion into the
MOM, where it oligomerizes and forms a pore that is respon-
sible for cyt c release (4,5). The pore hypothesis was
proposed based on structural similarities between the soluble
forms of the Bcl-2 proteins and the channel-like transloca-
tion domain of diphtheria toxin (6). Indeed, Bax exhibitsSubmitted July 30, 2012, and accepted for publication December 10, 2012.
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(cBid), Bax releases fluorescent molecules (including cyt c
and dextrans of several hundred kDa) from liposomes with
high efficiency and without altering vesicle integrity (7–9).
In addition, Bax forms large channels in vesicles and in black
lipid membranes with properties of lipid pores, also known
as toroidal pores (8,10).
However, antiapoptotic Bcl-2 proteins also permeabilize
model membranes (11–16). Current models for the action
of the Bcl-2 proteins in apoptosis do not explain these obser-
vations. To reconcile the pore activity of antiapoptotic Bcl-2
proteins with their prosurvival function in apoptosis, some
ideas proposed are that these proteins regulate other chan-
nels, such as ceramide, voltage-dependent anion, or ER
channels (17–20). Their inability to oligomerize could
also play a role. However, the mechanistic connection
between oligomerization and pore formation remains unex-
plained (21). The lack of experimental evidence integrating
the membrane activity of pro- and antiapoptotic proteins
according to their function has hindered resolution of this
long-standing problem.
Our aim in this work was to provide a better under-
standing of the general mechanisms of action of the Bcl-2
proteins and to tackle concretely the paradox between the
pore activities of pro- and antiapoptotic Bcl-2 proteins in
model membranes and their opposing roles in apoptosis.
For this purpose, we used a new method based on giant uni-
lamellar vesicles (GUVs). This single-vesicle approach
provides an unprecedented level of detail in the analysis
of the membrane-binding, oligomeric state and pore activity
of Bax and Bcl-xL. For this purpose, a chemically defined
system that avoids unwanted effects of unknown compo-
nents and allows the use of advanced microscopy techniques
is essential to discern the mechanistic differences between
Bax and Bcl-xL membrane activity.http://dx.doi.org/10.1016/j.bpj.2012.12.010
422 Bleicken et al.Our results provide, to our knowledge, novel information
about the molecular mechanism of membrane interaction
and pore formation of Bax and Bcl-xL. cBid binding to
membranes induces the insertion and activation of both Bax
and Bcl-xL. On the one hand, Bax follows an all-or-none
mechanism of membrane permeabilization. It is important
to note that, as we show, it oligomerizes while forming stable
pores. On the other hand, Bcl-xL is unable to self-assemble
and induces a graded permeabilization of the vesicles due
to transient alterations of the membrane permeability. More-
over, we found that once at themembraneBcl-xL inhibits Bax
membrane insertion. These findings are consistent with the
roles of these two proteins in apoptosis: while Bax self-orga-
nizes into long-lived pores large enough to release cyt c, Bcl-
xL transient permeabilization of pure lipid bilayers has no
consequences in the context of the MOM, which is naturally
permeable tomolecules<5 kDa. The physiological relevance
of these observations was further confirmed in a new MOM-
permeabilizing assay using isolated mitochondria. Interest-
ingly, these features of the membrane activity of Bax and
Bcl-xL are likely to be relevant also for their nonapoptotic
roles. Based on our findings, we propose to our knowledge,
new models for the membrane activity of Bax and Bcl-xL
that incorporate biophysical considerations and, for the first
time, integrate the different effects of these proteins on
MOM permeability during apoptosis.MATERIALS AND METHODS
Protein production and labeling
Full-lengthmouseBid and humanBax, and single-cysteinemutantsBidC30S
and Bax S4C, C62S, and C126S, as well as full-length human Bcl-xL C151A
and S4C, were expressed in Escherichia coli and purified and, in the case of
cBid, cleaved as described in Desagher et al. (3) and Bleicken et al. (5). We
used the same purification strategy for full-length Bcl-xL. Protein quality
was checked by sodium dodecyl sulfate polyacrylamide gel electrophoresis
and liquid chromatography-mass spectroscopy (micrOTOF LC, Bruker
Daltonics, Bremen, Germany). Alexa (Invitrogen, Darmstadt, Germany) or
Atto (Atto TEC, Siegen-Weidenau, Germany) dyes were covalently attached
to the cysteines of the mutants as described by the manufacturer. Proteins
labeled with Alexa488 or Atto488 are named cBidG, BaxG, or BcL-xlG,
and proteins labeled with Alexa633 or Atto655 are named cBidR, BaxR, or
Bcl-xLR. cBid was labeled with Alexa dyes and Bax and Bcl-xL with Atto
dyes. Bovine cyt c (Sigma, Munich, Germany) was labeled at lysines with
Alexa488 (cyt c-Al488) or Alexa633 (cyt c-Al633). Excess of label was
removed with desalting columns (BioRAD, Munich, Germany). The activity
of the labeled proteins was controlled with calcein release assays (Fig. S1).Calcein release assays
Egg PC and heart CL were from Avanti Polar Lipids (Hamburg, Germany).
Large unilamellar vesicles were prepared as in Garcı´a-Sa´ez et al. (22). Lipids
were mixed in chloroform, dried to thin films, and resuspended at 4 mg/ml in
80mMcalcein (Sigma) neutralizedwithNaOH, followedby repeated freezing
and thawing and extrusion through 100-nm polycarbonate membranes.
Nonencapsulated calcein was removed with PD10 columns (GE Healthcare,
Garching, Germany). Calcein release was detected on an Infinite M200 plate
reader (Tecan, Mainz, Germany) by the increase in fluorescence intensity.Biophysical Journal 104(2) 421–431Composition of the MOM-like lipid mixture
The lipid mixture mimicking the MOM composition was prepared as in
Lovell et al. (9) and Bleicken et al. (23) with 46% egg PC (L-a-phosphati-
dylcholine), 25% egg PE (L-a-phosphatidylethanolamine), 11% bovine
liver PI (L-a-phosphatidylinositol), 10% 18:1 phosphatidylserine, and 8%
cardiolipin (all percentages w/w).Membrane binding and permeabilization
Giant unilamellar vesicles (GUVs) were produced by electroformation (12).
Lipid mix (5 mg) in chloroform were spread on the platinum wires of the
electroformation chamber. After solvent evaporation, the wires were
immersed in 300 mM sucrose and electroformation proceeded for 2 h at
10 Hz at room temperature followed by 30 min at 2 Hz. Cyt c-Al488 or
free Al488 and Bcl-2 proteins in phosphate-buffered saline were mixed in
LabTec chambers (NUNC) blocked with casein. GUVs were added to the
sample at a ratio of 70/300 mL. In pore-stability experiments, 20 mL of
free Al633 or cyt c-Al633 were added after 90 min and images were
collected after 30 min.Pore-stability experiments on isolated
mitochondria
Wild-type mitochondria were isolated from Saccharomyces cerevisiae
DS1-2b (Y2197). To obtain matrix-targeted green fluorescent protein
(mt-GFP) mitochondria, S. cerevisiae DS1-2b was transformed with a
plasmid containing mt-GFP (pVT100U-mtGFP). Yeast cultures were grown
at 30C in rich YPG media (3% (v/v) glycerol as carbon source) to an
optical density between 1 and 2. Yeast mitochondria were prepared as in
Meisinger et al. (24). After cell homogenization, mitochondria were iso-
lated by differential centrifugation, and the crude mitochondrial pellet
was resuspended in ice-cold buffer (250 mM sucrose, 1 mM EDTA, and
10 mM MOPS-KOH, pH 7.2) at 8–10 mg/ml protein.
For experiments, mitochondria with or without mt-GFP were used. As
a first dye, DexG, (Al488-labeled 10 kDa Dextran) was mixed with buffer
(10 mM HEPES, 100 mM KCl, 1 mM EGTA, and 200 mM sucrose, pH
7.5) and the Bcl-2 proteins before mitochondria were added. After
45 min at 37C, the second dye, DexR (Al647-labeled 10 kDa Dextran),
was added and samples were incubated for 10 min at 37C before adding
agarose to 1%. In experiments using mt-GFP, no first dye was added, as
the green channel was used for the mt-GFP. To label fluorescently the mito-
chondria in experiments without mt-GFP, Bcl-xlR was added instead of the
second dye. Images were collected after gel hardening. In the indicated
experiments agarose was added at a temperature close to gel hardening,
so that the dextrans outside the mitochondria were diluted and the dye could
not equilibrate with the external medium.
Mitochondrial permeabilization was additionally measured by batch
experiments in a fluorimeter. After incubation at 37C the mitochondria
were separated by centrifugation (15,000  g, 10 min). The supernatant
was removed and the solid pellet carefully washed with 100 ml buffer
and afterwards resuspended in 200 ml buffer. The fluorescence intensity
of the mitochondrial fraction was measured in a fluorescence spectrometer
(Cary Eclipse, Varian, Darmstadt, Germany) (excitation, 345 nm; slit width,
5 nm; emission spectra, 650–750 nm).Confocal microscopy and fluorescence
correlation spectroscopy
All experiments were performed on an LSM710 microscope with a C-Apo-
chromat 40 1.2 water immersion objective (Zeiss, Oberkochen,
Germany). Excitation light came from Ar-ion (488 nm), HeNe (561 nm),
or HeNe lasers (633 nm). A spectral beam guide was used to separate
Differences in Bax and Bcl-xL Membrane Activity 423emitted fluorescence. Images were processed with ImageJ (http://rsbweb.
nih.gov/ij/), as described below.
We performed two-focus scanning fluorescence cross-correlation spec-
troscopy (FCCS) measurements at 22C using a Confocor 3 module.
Photon arrival times were recorded with a hardware correlator Flex
02-01D/C (http://correlator.com). We repeatedly scanned the detection
volume with two perpendicular lines across a GUV equator (the distance
between the two lines, d, was measured by photobleaching on a film of
dried fluorophores). Data analysis was performed with our own software
(see Garcı´a-Sa´ez et al. (12)). We binned the photon stream in 2 ms and ar-
ranged it as a matrix such that every row corresponded to one line scan. We
corrected for membrane movements by calculating the maximum of
a running average over several hundred line scans and shifting it to the
same column. We fitted an average over all rows with a Gaussian and we
added only the elements of each row between 2.5 s and 2.5 s to construct
the intensity trace. We computed the autocorrelation and spectral and
spatial cross-correlation curves from the intensity traces and excluded
irregular curves resulting from instability and distortion. We fitted the
auto- and cross-correlation functions with a nonlinear least-squares global
fitting algorithm, as in Garcı´a-Sa´ez et al. (12). FCCS was corrected for
cross talk (5%) and for labeling degree (100% for BaxG, 80% for BaxR,
90% for Bcl-xLG, and 70% for Bcl-xLR).Image analysis
The percentage of GUV filling was calculated as"
ðFint  F0Þ
ðFoutt  F0Þ
#
 100; (1)FIGURE 1 Bax and Bcl-xL binding to GUVs depends on cBid and CL. (A and
80:20 (mol/mol) after 60 min incubation at room temperature, showing Bcl-xL
binding to GUVs in the absence and presence of Bcl-xLR (B). Scale bar, 25 mM. (
to GUVs with different lipid compositions. M indicates a lipid mixture mimickwhere Ft
in and Ft
out are the average fluorescence intensities inside and
outside a GUV, and F0 is the background fluorescence at time t. We arbi-
trarily set the threshold for a nonpermeabilized GUV to <15%. Several
hundreds of GUVs were analyzed per experiment.
To quantify protein binding to GUV membranes, the fluorescence inten-
sity at the vesicle rim (Frim) was calculated with Image J using the plug-in
radial profile plot. For Fig. 1, intensity was plotted as Frim/Fback, where
Fback is the background intensity outside the GUVs.
In the kinetics experiments, images were recorded every 20 s and
changes in the fluorescence intensity inside GUVs were analyzed over
time as
FNt ¼
"
ðFint  F0Þ
ðFoutt  F0Þ
#
; (2)
where Ft
N is the normalized fluorescence intensity at time t.
To calculate the initial A0 and relaxed Arelax permeabilized area of
individual GUVs, as well as the relaxation time trelax, we used a multiexpo-
nential fitting described by Eq. 7:
FðtÞNin ¼ 1 e
t
tfluxðtÞ; (3)
where the influx rate, tflux, decreases with time (the initial pore size relaxes
to a smaller structure) according to
tfluxðtÞ ¼ V
AðtÞ  D
m
; (4)B) Confocal images and radial profiles of individual GUVs made of PC/CL
R binding to GUVs in the absence and presence of cBidG (A) and cBidG
C–F) Bcl-2 proteins BaxG (C), cBidR (D), Bcl-xl (E), and cBidG (F) binding
ing a MOM containing 6% CL (mol/mol).
Biophysical Journal 104(2) 421–431
424 Bleicken et al.where V is the vesicle volume, D the dye diffusion coefficient, m the
membrane thickness, and A the total permeabilized area, which varies
with time according to
AðtÞ ¼ Arelax þ ðA0  ArelaxÞ  e
t
trelax : (5)
Membrane thickness was assumed to be 4.5 nm. The diffusion coefficient of
cyt c-al488 was 196 mm2/s (1965 27 mm2/s) as calculated by fluorescence
correlation spectroscopy (FCS).RESULTS
Bax and Bcl-xL compete for membrane
association induced by cBid
To compare the permeabilizing activity of Bax and Bcl-xL,
it is essential to analyze their membrane association. We
directly visualized and quantified protein binding to
membranes by the increase in fluorescence intensity on the
rim of individual GUVs (Fig. 1, A and B, and Fig. S3).
cBid enables Bax, as well as Bcl-xL, insertion into the
MOM and into model membranes (12,21). In agreement
with its role as a receptor (7,12), we observed that membrane
binding of cBid (labeled with Al633 or Al488 (cBidR or G))
depends on cardiolipin (CL) and increases with CL concen-
tration (Fig. S2). Interestingly, cBidR or G binding to a lipid
mixture that mimics the MOM (see Materials and Methods)
and contains 6% CL (mol/mol) was too weak to be detected
using this method (Fig. 1 D). This weak binding is in line
with previous results using different methods (23).
In the case of Bax (labeled with Atto488 (BaxG) or Atto
655 (BaxR)), its association depended on the presence of
both cBid and CL (Fig. 1, C and D, and Fig. S3). Using
the mixture mimicking the MOM, BaxG or R bound to
GUVs, but it was close to the detection limit, and with
20% CL the contrast was still weak. By increasing CL
content to 33%, we clearly visualized BaxG or R membrane
association (Fig. 1 C). When Bcl-xL was present, BaxG or R
binding to GUVs was reduced (Fig. 1 C), as in experiments
using bulk assays (21). However, cBidR or G binding was not
significantly affected (Fig. 1 D). This shows that Bcl-xL can
inhibit Bax action by blocking its membrane association,
probably by sequestration of cBid on the membrane, as their
most favorable interaction takes place within the lipid
bilayer (12).
Bcl-xLR or G binding to CL-containing membranes was
promoted by cBidG or R and, vice versa, Bcl-xLR or G
increased cBidG or R concentration at the membrane
(Fig. 1, A, B, E, and F, and Fig. S3). In agreement with
this, increasing the CL concentration enhanced Bcl-xL
binding to the membrane. Interestingly, for the MOM-like
lipid mixture, cBidG binding to the membrane was only
clearly detected in the presence of Bcl-xL (Fig. 1 D). In
contrast to the effect of Bcl-xL onBaxG or R binding, the pres-
ence of Bax did not affect the association of Bcl-xLR or Gwith
GUVs (Fig. 1 E).Biophysical Journal 104(2) 421–431Bax and Bcl-xL permeabilize membranes with
different mechanisms
Membrane permeabilization was directly visualized by
monitoring the entry of a dye into the lumen of the GUVs
initially devoid of dye. With this method, the kinetics and
the extent of permeabilization can be quantified for indi-
vidual vesicles in the sample. This allows the identification
of subpopulation effects, which is not possible in traditional
bulk experiments. Moreover, preferences for certain
membrane types can be directly assessed by mixing GUVs
of different compositions in a situation closer to the coexis-
tence of membranes in a cell.
We mixed GUVs composed of PC (green) and PC/CL 8:2
(red) in a buffer containing cyt c-Al488 (green) and Bcl-2
proteins (Fig. 2 A). In the presence of cBid and Bax or
Bcl-xL, we found permeabilization of vesicles containing
CL, but not pure PC, illustrating the specific effect of CL
on the membrane activity of these Bcl-2 proteins. In the
presence of CL, only the combination of cBid with Bax,
Bcl-xL, or a mixture of the two caused a dramatic increase
in the fraction of permeabilized vesicles (Fig. 2 B). A similar
result was obtained when the GUVs were produced with the
MOM-like lipid mixture (Fig. 2 B). The only detectable
difference between PC/CL 8:2 and the MOM-like lipid
mixture is permeabilization at a lower, but still present,
rate by cBid and Bcl-xL in the latter. It is important to
note that membrane permeabilization usually occurred
without vesicle disruption. Bax was faster than Bcl-xL at
permeabilizing the vesicles in the sample and, unlike its anti-
apoptotic counterpart, tended to burst part of the GUVs after
long incubation times.
By comparing the fluorescence inside the individual
GUVs with that of the background, one can calculate the
filling degree after a certain incubation time. Two situations
are distinguished. In the all-or-none mechanism of mem-
brane permeabilization, the vesicles in the sample exhibit
two states, impermeable or totally permeabilized. Alterna-
tively, the individual GUVs in the sample can exhibit
a varying degree of filling according to the graded mecha-
nism. In Bax-permeabilized GUVs, the distribution of filling
degrees is typical of an all-or-none mechanism both for the
PC/CL 8:2 and the MOM-like lipid mixture (Fig. 2 C and
Fig. S4). In contrast, the vesicle population in the samples
incubated with Bcl-xL spans a large range of filling degrees,
following a graded mechanism of permeabilization, again
found in both lipid mixtures.
We quantified the permeabilization kinetics of single
vesicles in PC/CL 8:2 (Fig. 2, D–G, Movie S1, and Movie
S2). They were permeabilized stochastically, but we aligned
the starting point of permeabilization for clarity. The filling
rate of GUVs incubated with Bax was very fast, and most
vesicles reached 50% filling after a few seconds. This
process was slower in GUVs permeabilized by Bcl-xL,
which in some cases did not reach the totally permeabilized
FIGURE 2 Bax and Bcl-xL follow different mechanisms of membrane permeabilization. (A) The internalization of cyt c-Al488 into the lumen of the indi-
vidual vesicles indicates membrane permeabilization. Green GUVs composed of PC 0.05%DiO and red GUVs of PC/CL 8:2 0.05%DiD. Images were taken
90 min after mixing the components. Scale bar, 75 mm. (B) Fraction of nonpermeabilized GUVs in the presence of Bcl-2 proteins. Gray bars correspond to PC
GUVs, red bars to GUVs containing 20% CL, and blue bars to a mixture mimicking the MOM. (C) Distribution of degree of filling of the GUVs after 90 min
incubation with cBid/Bax (red bars) and cBid/Bcl-xL (blue bars). GUVs were composed of PC/CL 8:2 0.05%DiD. In each of three experiments, a minimum
of 250 vesicles were analyzed. (D and E) Time-lapse images of the permeabilization of GUVs (grayscale) to cyt c-al488 (green) induced by cBid/Bax (D) or
cBid/Bcl-xL (E). Scale bar, 25 mm. (F and G) Filling kinetics measured by the increase of fluorescence intensity inside of individual GUVs (different colors)
incubated with cBid/Bax (F) or cBid/Bcl-xL (G). Normalized data are shown in dots and fitting curves in lines. (H and I) Estimated radius of the initial (H)
and relaxed (I) total pore area of individual GUVs after incubation with cBid/Bax (red) or cBid/ Bcl-xL (blue). Outliers are shown in gray. Protein concen-
tration was 10 nM for cBid, 20 nM for Bax,, and 50 nM for Bcl-xL.
Differences in Bax and Bcl-xL Membrane Activity 425state. To properly compare the kinetics, we calculated
the totally permeabilized area/vesicle induced by Bax or
Bcl-xL as described previously (25,26) (Fig. 2, H and I).
The initial filling proceeded faster than at later stages.
This has been extensively investigated by Fuertes et al.
(25), who showed that the two-component filling kinetics
of GUVs can be explained by the relaxation of the initialmembrane openings to smaller pores. In the case of Bax,
the calculated average radius of the initial total pore area
is 72 5 28 nm, which relaxed to an average size of 7 5
3 nm. In contrast, the area permeabilized by Bcl-xL was
much smaller, with an average initial radius of 115 4 nm
that relaxed to 2 5 1 nm. This indicates that the total size
of the membrane lesions induced by Bax is significantlyBiophysical Journal 104(2) 421–431
426 Bleicken et al.larger than those promoted by Bcl-xL and that the kinetics
of membrane permeabilization by Bax are faster than those
of its antiapoptotic counterpart.FIGURE 3 Unlike Bcl-xL, Bax induces stable pores in lipid membranes.
(A and B) GUVs in the presence of cBid and Bax or Bcl-xL after 2 h incu-
bation. PC/CL 8:2 0.05% DiI GUVs (second panel) and Al488 (first panel)
were added simultaneously with the proteins, and Al633 (third panel) was
added after the 90-min incubation. Merged images are shown in the fourth
panel. (C–E) Filling degree of individual, permeabilized GUVs to Al488
(green bars) and Al633 (red bars) after incubation in the presence of
cBid/Bax (C), cBid/Bcl-xL (D), or without proteins (E). (F) Fraction of
GUVs with stable pores (>50% filling with both Al488 and Al633) from
five independent experiments. Error bars represent the SD. Unpaired two-
tailed t-test, p value < 0.001.Unlike Bcl-xL, Bax forms long-lived membrane
pores that correlate with homooligomerization
The results above suggest that the pores induced by Bax
evolve into structures that allow the passage of large mole-
cules across the membrane, whereas those induced by
Bcl-xL tend to close after a certain time. To investigate
this in more detail, we evaluated the stability of the perme-
ability alterations induced by Bax and Bcl-xL. After incu-
bating the GUVs in a buffer containing Al488 and the
proteins of interest, we added Al633 to see whether the vesi-
cles permeabilized to Al488 were still permeable to the
second marker (Fig. 3, A and B) (25,27). With this system
we cannot distinguish whether the individual pores are
opening and closing or whether they stay continuously
open during the experiment, but we can monitor whether
the membrane is still in a permeabilized state after the incu-
bation time. In the control (Fig. 3 E), only a small fraction of
the few permeabilized vesicles were permeable to the
second marker. In the presence of Bax, the vast majority
of vesicles filled with Al488 were also permeable to
Al633 (Fig. 3 C), demonstrating that Bax forms pores for
a long period of time. In contrast, the number of vesicles
permeable to both dyes was much lower for Bcl-xL
(Fig. 3 D), indicating that the membranes closed after
a certain period of time. We obtained similar results with
fluorescent cyt c and lipid mixture mimicking the MOM
(Fig. S5). Our findings show that Bax and Bcl-xL exhibit
differences in stability of the membrane perturbations they
induce (Fig. 3 F): whereas Bax induces long-lived pores,
Bcl-xL promotes transient alterations of the membrane
permeability.
The GUV system also offers the possibility of directly
measuring the oligomeric state of the membrane-inserted
conformation of Bax and Bcl-xL by FCCS, a technique
with singlemolecule sensitivity that quantifies dynamic
codiffusion of biomolecules online (28). To investigate the
oligomeric state of Bax and Bcl-xL under our experimental
conditions, we quantified complex formation between BaxR
and BaxG, or Bcl-xLR and Bc-xLG, added to unlabeled
GUVs in the presence of cBid (Fig. 4). The amplitude of
the FCS autocorrelation curves is inversely proportional to
the concentration of proteins, in this case red and green
Bax or Bcl-xL in the membrane (Fig. 4, A and B, green and
red lines). In line with Fig. 1, the concentration of Bax in
the membrane was lower than that of Bcl-xL. In contrast,
the amplitude of the FCCS curves (Fig. 4,A andB, blue lines)
is directly proportional to the number of particles in
a complex containing at least one red and one green protein.
While fluorescent Bax showed positive cross-correlation
indicative of oligomerization, Bcl-xL showed no significantBiophysical Journal 104(2) 421–431cross-correlation, showing the inability of the protein to
self-assemble. In GUVs with higher concentrations of Bax,
we detected bright dots (large oligomers or aggregates)
with colocalized red and green Bax molecules (100%
cross-correlation). For technical reasons, these GUVs were
not included in the FCS analysis due to their high brightness
and spatial heterogeneity. Fig. 4 C shows, for several indi-
vidual vesicles, the percentage of Bax or Bcl-xL particles
that form part of a complex within the GUV membrane, as
calculated from the FCCS experiments.
FIGURE 4 Bax, but not Bcl-xL, oligomerizes in the membrane of GUVs. (A and B) Confocal images, auto- (orange and green), and cross-correlation
(blue) curves from two-focus scanning FCCS measurements in the membranes of GUVs using BaxG/BaxR (A) or Bcl-xLG/Bcl-xLR (B) in the presence
of cBid. Straight lines correspond to fitted curves and dotted lines to the raw data. Scale bar, 10 mm. (C) Percent complex between Bax and Bcl-xL molecules
in individual GUVs. Unpaired two-tail t-test, p value < 0.001.
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isolated mitochondria
The detailed level of analysis of membrane permeabiliza-
tion obtained in GUVs cannot be achieved with higher bio-
logical systems. However, the MOM contains a much more
complex protein-lipid composition than the GUVs. To test
whether our results are valid under more physiological
conditions, we developed a new method to study the
stability of membrane permeabilization in isolated mito-
chondria. This method provides the complexity of a mito-
chondrial microenvironment. As a control that we obtain
mainly mitochondria and not other organelles, we isolated
mitochondria labeled with mt-GFP parallel to wild-type
mitochondria (Fig. S6). To avoid the unwanted effects of
endogenous Bcl-2 proteins, we used mitochondria from
S. cerevisiae.
To follow MOM permeabilization, we added fluorescent
10 kDa dextrans (DexR or DexG) to the external buffer,
a strategy similar to that used with the GUVs (DexG at
t ¼ 0; DexR at t ¼ 45 min). After 55 min incubation at
37C, the mitochondria remained impermeable in the buffer
control (Fig. 5 C). In batch experiments, we compared the
amount of DexR in sedimented mitochondria after incuba-
tion with cBid/Bax or cBid/Bcl-xL or buffer control
(Fig. 5, A and B). We measured the emission spectra and
compared the fluorescence intensities of the different
samples (Fig. 5, A and B). Incubation with cBid/Bax led
to a higher DexR concentration in the mitochondria
compared to the buffer control, whereas cBid/Bcl-xL
showed no significant difference. These results demonstrate
that cBid/Bax but not cBid/Bcl-xL form stable pores in
mitochondria, similar to our observations for the GUVs.Moreover, we used a confocal microscope to visualize the
dextran entrance into single mitochondria (Fig. 5 and
Fig. S7). Under control conditions and in the presence of
cBid and Bcl-xL, DexG and DexR were only found outside
the mitochondria (Fig. 5, C and D, and Fig. S7, A and C),
indicating that most mitochondria were not permeabilized.
On the contrary, when incubated with Bax and cBid, both
dextrans could enter the mitochondria (Fig. 5 E and
Fig. S7 B). We used a dilution strategy of the medium
outside the mitochondria that led to a higher dextran concen-
tration inside the permeabilized organelles (Fig. 5 F and
Fig. S7). As an additional control, we added Bcl-xLR at
the end of the incubation to label the MOM (Fig. 5 G and
Fig. S7 D). The images also show that cBid and Bax induce
a stable permeabilization of theMOM, in agreement with the
batch experiments and the assays with GUVs.
In contrast, Bcl-xL and cBid did not induce mitochondrial
permeabilization (Fig. 5 D and Fig. S7 C), not even for
dextran added at t ¼ 0. This result varies from the results
found on GUVs and suggests that the microenviroment of
the mitochondria alters the membrane-permeabilizing
activity of Bcl-xL.DISCUSSION
To better understand the membrane activity of pro- and anti-
apoptotic Bcl-2 proteins, and to integrate this with their
function in apoptosis, here we have carried out a comparison
at the single vesicle levle of their membrane binding, oligo-
merization and permeabilizing activity.
In our binding studies, we found that cBid promotes associ-
ation of bothBax andBcl-xLwithCL-containingmembranes.Biophysical Journal 104(2) 421–431
FIGURE 5 Bax stably permeabilizes isolated yeast mitochondria. (A)
Fluorescence spectra of pelleted yeast mitochondria incubated with DexR
and buffer (black); 50 nM cBid and 100 nM Bax (red); or 50 nM cBid
and 200nM Bcl-xL (blue). (B) Mean 5 SD of the fluorescence intensity
in the pellet fraction at 667 nm (from five independent experiments). (C–
G) Confocal images of isolated yeast mitochondria after incubation with
buffer (C), Bcl-xL/cBid (D), or Bax/cBid in the presence of DexG (added
at time 0) (E–G) and DexR (C–F) or Bcl-xLR added after 45 min incubation
(G). In F agarose was added at a temperature suitable to fast gel hardening
>1 min, so that the dextrans in the medium are diluted and no equilibration
with the dextrans inside the mitochondria can take place. Images in C–G are
(left to right) the transmission image, DexG (green), DexR or Bcl-xLR (red),
and a merge of the red and green channels. Protein concentrations were
50 nM cBid, 100 nM Bax, 200 nM Bcl-xL, or 50 nM Bcl-xLR (in G). Scale
bar, 5 mm.
428 Bleicken et al.To perform this function, cBid had to be able to bind to the
target membrane, and this binding depended on the mem-
brane’s CL content. This supports the role of CL as a receptor
for cBid (29) and suggests that cBid itself functions as a
receptor for Bax and Bcl-xL. Bcl-xL membrane binding in-
duced by cBid was more efficient than that of Bax, indicatingBiophysical Journal 104(2) 421–431that the differences in pore activity between the two proteins
are not due to amore efficient binding ofBax to themembrane.
Interestingly, Bcl-xL, but not Bax, increased cBid binding
to CL-containing GUVs, which could be explained by the
strong tendency of these two proteins to form complexes
within the lipid bilayer (12). In addition, we found that
Bax did not affect Bcl-xL binding to GUVs. These findings
highlight a difference in the respective mechanisms of
action of Bax and Bcl-xL, probably due to the inability of
Bax to compete with Bcl-xL for cBid binding. One could
hypothesize that cBid/Bcl-xL complex formation would
free cardiolipin molecules, which would then be able to
act again as receptors and induce the membrane binding
of additional cBid molecules. Moreover, as long as Bcl-xL
sequesters cBid at the membrane, the latter is likely unable
to interact with Bax, thus providing an explanation of
how Bcl-xL can inhibit Bax binding to the membrane and
therefore also its apoptotic action (also described by Billen
et al. (21)).
Bax followed an all-or-none mechanism, with the lipo-
some population divided into completely filled or intact
vesicles (27). This implies that as Bax binds to the
membrane, its impermeability is retained up to a threshold
concentration (30,31), at which point the opening of one
or more pores that allow complete vesicle filling is induced.
Interestingly, the kinetics of single-vesicle filling shows
a two-component kinetics, with an initial larger permeabi-
lized area that relaxes to a smaller size. This has been
observed already for pores induced by Bax-derived peptides
(25), and it may be a general feature of proteins inducing
lipid pores, also known as toroidal pores. It is important to
note that the average total size of Bax pores in conditions
close to equilibrium is 7 5 3 nm, large enough to allow
the passage of proteins like cyt c across the membrane.
Therefore, our findings demonstrate that Bax has the ability
to form long-lived pores that are large enough to release
proteins across pure lipid membranes, as well as in isolated
mitochondria. This reproduces the processes involved in
MOM permeabilization during apoptosis.
Interestingly, the features of membrane permeabilization
by Bcl-xL were very different from those exhibited by Bax.
Bcl-xL followed a graded mechanism of permeabilization,
with most vesicles only partially filled. This is typical for
small and transient alterations of membrane permeability,
which do not allow the vesicle interior to reach equilibrium
with the external medium. Although the initial total pore
area was considerable and allowed the passage of proteins
the size of cyt c, these alterations evolved to very small
structures, which do not allow the passage of molecules
R2 nm radius, and to eventual closure. Moreover, we also
found that Bcl-xL was unable to induce a stably permeabi-
lized membrane. This shows that the activity of Bcl-xL
observed in artificial membranes is the result of transient
alterations of the bilayer permeability likely associated
with membrane insertion, which disappear as the system
Differences in Bax and Bcl-xL Membrane Activity 429evolves toward equilibrium. In agreement with this, we did
not find permeabilization of isolated mitochondria, which
have a very different microenvironment compared to the
pure lipid bilayer of GUVs. However, once in the
membrane, Bcl-xL is able to exclude Bax from the
membrane and thereby prevent MOM permeablization.
Moreover, membrane-inserted Bcl-xL can act as an interac-
tion partner with other proteins related to nonapoptotic func-
tions. In this context, interaction of subapoptotic amounts of
Bax with Bcl-xL could hinder binding of Bcl-xL to other
proteins and thus have an effect on alternative functions
not related to membrane permeabilization.Models for Bax and Bcl-xL membrane activity
Computational studies using molecular dynamics have
shown that lipid pores have a rather disordered toroidal
shape (32). Direct evidence for such pore structures was first
described for a peptide derived from helix 5 from Bax (33).
According to a continuum model, the energy, E, of a pore in
a lipid membrane can be described as
EðrÞ ¼ 2pgr  psr2; (6)
where r is the radius of the pore, g is the line tension asso-
ciated with the energy cost of the highly curved membrane
at the pore edge (due to imperfect lipid packing), and s is the
membrane tension, which originates from a stress source
and represents the potential for mechanical work of pore
expansion (34). As a result, pores are metastable structures,
with the membrane tension tending to enlarge the pore and
line tension tending to close it.
The mechanism of pore-forming polypeptides usually
involves two steps: 1), the introduction of membrane stress
that decreases the activation energy of pore opening (35);
and 2), a decrease of line tension to stabilize the open stateof the pore. Once formed, the pore itself constitutes a
mechanism to relieve the membrane tension, which leads
to relaxation of the pore size (25,36) and to final closure.
The asymmetric insertion of these polypeptides into the
accessible membrane leaflet introduces additional area,
which leads to membrane thinning (37,38). This raises the
membrane tension up to a level at which the opening of
a pore is no longer unfavorable. In our experiments,
membrane insertion of Bcl-xL and Bax constitutes an asym-
metric attack on the lipid bilayer that introduces membrane
tension and induces pore opening in both cases (Fig. 6). In
the case of Bax, the additional effect of oligomerization
effectively produces a local increase of the membrane
tension that increases the efficiency of pore opening
compared to that of Bcl-xL, which does not self-associate.
Once the pore is open, it will evolve toward closure unless
line tension is decreased. We showed previously that helix
a5 of Bax exhibits such an attenuation of line tension corre-
lating with the formation of stable pores (25,30), in agree-
ment with what is observed here for full-length Bax. Bax
oligomerization also has an effect on pore stabilization,
increasing the efficiency of line-tension relief, as it ensures
a high number of pore-forming proteins at the pore rim. In
contrast, Bcl-xL pores evolved toward a closed state over
time, indicating the inability of this protein to relieve line
tension. Based on Bcl-xL inhibition of Bax self-assembly,
previous models have made a link between Bax oligomeri-
zation and its ability to permeabilize the MOM (21).
However, to our knowledge, this is the first time that the
role of oligomerization has been included in the molecular
mechanism of stable pore formation by Bax.Implications in apoptosis and other functions
These observations are relevant in the context of biological
membranes, which modulate their membrane tension (39).FIGURE 6 Models for membrane activity of
Bax and Bcl-xL. (A) The membrane tension associ-
ated with Bax binding to the accessible membrane
leaflet is locally elevated by oligomerization. This
increases the efficiency of pore opening, which is
then stabilized by a decrease in line tension
promoted by Bax. Bax oligomerization most likely
also increases the line-tension attenuation and thus,
pore stability. (B) Upon membrane binding, Bcl-xL
also increases the membrane tension, although less
efficiently. When the membrane tension is suffi-
ciently high, a pore opens. As the membrane
tension is relieved, and since Bcl-xL does not
attenuate the line tension, the pore will close.
Biophysical Journal 104(2) 421–431
430 Bleicken et al.In the MOM, naturally permeable to molecules up to 5 kDa,
the increase of membrane tension associated with Bcl-xL
insertion is dissipated with small, transient membrane reor-
ganizations that do not affect the overall MOM perme-
ability. In contrast, Bax insertion and oligomerization
ensures a local increase of membrane tension, leading to
the opening of a pore that is efficiently stabilized by the
line-tension-attenuating effect of the protein. As a result,
MOM permeability is altered and the apoptotic factors are
released into the cytosol, as we found in the studies of
pore stability with isolated mitochondria.
Despite the lack of information regarding the mechanisms
involved, the membrane-associated form of the Bcl-2
proteins is crucial for their nonapoptotic functions. The
results reported here should be taken into account when
investigating these alternative roles. For example, Bcl-xL
increases the probability of the open state of voltage-depen-
dent anion channel (40) and regulates ER Ca2þ content by
modulating the activity of IP3R (41). This ability of Bcl-xL
to modulate the permeability of the MOM to small mole-
cules is compatible with our results and may have implica-
tions for mitochondrial metabolism. Moreover, Bcl-xL also
interacts with Beclin-1 at the ER to regulate autophagy via
mechanisms that are likely related to Ca2þ homeostasis
(1,42). Another example is mitochondrial dynamics. Bax
has been shown to colocalize at the mitochondrial fission
sites with proteins regulating mitochondrial fusion and
fission, Mfn2 and Drp1, and to modulate their activities
(43). On the other hand, Drp1 promotes Bax apoptotic
activity via a mechanism based on membrane curvature
(44). In this context, the ability of Bax to stabilize open
pores by decreasing the line tension at the pore edge (as
proposed in our model) is likely to also play a role in stabi-
lizing the highly curved membrane generated at the mito-
chondrial fission and fusion sites.
Our in-depth comparison of the membrane activity of Bax
and Bcl-xL reveals profound differences in the molecular
mechanisms of action of these proteins that are relevant to
their biological functions. This explains why Bcl-xL, despite
permeabilizing model membranes, does not induce MOM
permeabilization in apoptotis, as its homolog Bax does. In
contrast to Bax and their bacterial analogs, Bcl-xL does
not behave as a pore-forming protein in the complex micro-
environment of the MOM, as observed in the experiments
with isolated yeast mitochondria. Bcl-xL is nevertheless
able to insert into intracellular membranes and interact
with other proteins from the Bcl-2 family and beyond to
regulate apoptosis, as well as to fulfill other functions.
However, it does not induce the permeabilization of these
intracellular membranes. In a different membrane environ-
ment, like the protein-free liposomes, Bcl-xL does exhibit
membrane-permeabilizing activity. In this sense, our results
integrate, for the first time, the behavior in membranes of
highly homologous proteins like Bax and Bcl-xL with their
different apoptotic functions.Biophysical Journal 104(2) 421–431CONCLUSIONS
To summarize, our comparison of membrane activity of Bax
and Bcl-xL at the single-vesicle level demonstrates funda-
mental differences in the membrane interaction and organi-
zation of these two proteins. On the one hand, Bax and
Bcl-xL insert into membranes in a cBid-dependent manner
and thereby disturb membrane integrity. On the other hand,
once inserted, Bax and Bcl-xL behave quite differently.
Although Bax oligomerizes to form stable pores that are
large enough to release proteins, Bcl-xL induces small, tran-
sient alterations of the membrane permeability without
consequences for the MOM. Moreover, Bcl-xL is able to
inhibit Bax membrane insertion and therefore MOM perme-
abilization. These differences integrate the membrane
activity of these proteins in model membranes with their
different effects on MOM permeability during apoptosis.SUPPORTING MATERIAL
Seven figures and two movies are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(12)05121-1.
We thank J. Suckale for careful reading of the manuscript and C. Stegmu¨ller
and S. Gu¨nther for technical support. pVT100U-mtGFP was a generous gift
from B. Westermann, and DS1-2b (Y2197) kindly given by E. Hurt. We
also thank D. P. Herten and A. Rybina for supporting us with the fluores-
cence spectrometer.
This work was supported by the Max Planck Society, the German Cancer
Research Center and the German Ministry for Education and Research
(BMBF, grant N.0312040).REFERENCES
1. Danial, N. N., A. Gimenez-Cassina, and D. Tondera. 2010. Homeo-
static functions of BCL-2 proteins beyond apoptosis. In Bcl-2 Protein
Family. Essential Regulators of Cell Death. C. Hetz, editor. Springer,
New York. 1–32.
2. Garcı´a-Sa´ez, A. J., G. Fuertes,., J. Salgado. 2010. Permeabilization
of the outer mitochondrial membrane by Bcl-2 proteins. Adv. Exp.
Med. Biol. 677:91–105.
3. Desagher, S., A. Osen-Sand, ., J. C. Martinou. 1999. Bid-induced
conformational change of Bax is responsible for mitochondrial cyto-
chrome c release during apoptosis. J. Cell Biol. 144:891–901.
4. Eskes, R., S. Desagher,., J. C. Martinou. 2000. Bid induces the olig-
omerization and insertion of Bax into the outer mitochondrial
membrane. Mol. Cell. Biol. 20:929–935.
5. Bleicken, S., M. Classen,., E. Bordignon. 2010. Molecular details of
Bax activation, oligomerization, and membrane insertion. J. Biol.
Chem. 285:6636–6647.
6. Antignani, A., and R. J. Youle. 2006. How do Bax and Bak lead to per-
meabilization of the outer mitochondrial membrane? Curr. Opin. Cell
Biol. 18:685–689.
7. Kuwana, T., M. R. Mackey,., D. D. Newmeyer. 2002. Bid, Bax, and
lipids cooperate to form supramolecular openings in the outer mito-
chondrial membrane. Cell. 111:331–342.
8. Terrones, O., B. Antonsson,., G. Basan˜ez. 2004. Lipidic pore forma-
tion by the concerted action of proapoptotic BAX and tBID. J. Biol.
Chem. 279:30081–30091.
Differences in Bax and Bcl-xL Membrane Activity 4319. Lovell, J. F., L. P. Billen,., D. W. Andrews. 2008. Membrane binding
by tBid initiates an ordered series of events culminating in membrane
permeabilization by Bax. Cell. 135:1074–1084.
10. Basan˜ez, G., A. Nechushtan,., R. J. Youle. 1999. Bax, but not Bcl-xL,
decreases the lifetime of planar phospholipid bilayer membranes
at subnanomolar concentrations. Proc. Natl. Acad. Sci. USA. 96:
5492–5497.
11. Peng, J., J. Ding,., J. Lin. 2009. Oligomerization of membrane-bound
Bcl-2 is involved in its pore formation induced by tBid. Apoptosis.
14:1145–1153.
12. Garcı´a-Sa´ez, A. J., J. Ries,., P. Schwille. 2009. Membrane promotes
tBID interaction with BCL(XL). Nat. Struct. Mol. Biol. 16:1178–1185.
13. Schlesinger, P. H., A. Gross,., S. J. Korsmeyer. 1997. Comparison of
the ion channel characteristics of proapoptotic BAX and antiapoptotic
BCL-2. Proc. Natl. Acad. Sci. USA. 94:11357–11362.
14. Lam, M., M. B. Bhat,., C. W. Distelhorst. 1998. Regulation of Bcl-xl
channel activity by calcium. J. Biol. Chem. 273:17307–17310.
15. Minn, A. J., P. Ve´lez,., C. B. Thompson. 1997. Bcl-x(L) forms an ion
channel in synthetic lipid membranes. Nature. 385:353–357.
16. Schendel, S. L., Z. Xie, ., J. C. Reed. 1997. Channel formation by
antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:5113–5118.
17. Shimizu, S., A. Konishi,., Y. Tsujimoto. 2000. BH4 domain of anti-
apoptotic Bcl-2 family members closes voltage-dependent anion
channel and inhibits apoptotic mitochondrial changes and cell death.
Proc. Natl. Acad. Sci. USA. 97:3100–3105.
18. Siskind, L. J., T. X. Yu,., M. Colombini. 2007. Bcl-xL closes ceram-
ide channels. Biophys. J. (Suppl. S):569A–570A.
19. Rong, Y. P., G. Bultynck,., C. W. Distelhorst. 2009. The BH4 domain
of Bcl-2 inhibits ER calcium release and apoptosis by binding the regu-
latory and coupling domain of the IP3 receptor. Proc. Natl. Acad. Sci.
USA. 106:14397–14402.
20. Szegezdi, E., D. C. Macdonald, ., A. Samali. 2009. Bcl-2 family on
guard at the ER. Am. J. Physiol. Cell Physiol. 296:C941–C953.
21. Billen, L. P., C. L. Kokoski,., D. W. Andrews. 2008. Bcl-XL inhibits
membrane permeabilization by competing with Bax. PLoS Biol.
6:e147.
22. Garcı´a-Sa´ez, A. J., M. Coraiola,., J. Salgado. 2006. Peptides corre-
sponding to helices 5 and 6 of Bax can independently form large lipid
pores. FEBS J. 273:971–981.
23. Bleicken, S., A. J. Garcı´a-Sa´ez, ., E. Bordignon. 2012. Dynamic
interaction of cBid with detergents, liposomes and mitochondria.
PLoS ONE. 7:e35910.
24. Meisinger, C., N. Pfanner, and K. N. Truscott. 2006. Isolation of yeast
mitochondria. Methods Mol. Biol. 313:33–39.
25. Fuertes, G., A. J. Garcı´a-Sa´ez, ., J. Salgado. 2010. Pores formed by
Baxa5 relax to a smaller size and keep at equilibrium. Biophys. J.
99:2917–2925.
26. Scho¨n, P., A. J. Garcı´a-Sa´ez,., P. Schwille. 2008. Equinatoxin II per-
meabilizing activity depends on the presence of sphingomyelin and
lipid phase coexistence. Biophys. J. 95:691–698.
27. Apella´niz, B., J. L. Nieva, ., A. J. Garcı´a-Sa´ez. 2010. All-or-none
versus graded: single-vesicle analysis reveals lipid composition effects
on membrane permeabilization. Biophys. J. 99:3619–3628.28. Garcı´a-Sa´ez, A. J., and P. Schwille. 2008. Fluorescence correlation
spectroscopy for the study of membrane dynamics and protein/lipid
interactions. Methods. 46:116–122.
29. Lutter, M., M. Fang, ., X. Wang. 2000. Cardiolipin provides speci-
ficity for targeting of tBid to mitochondria. Nat. Cell Biol. 2:754–761.
30. Garcı´a-Sa´ez, A. J., S. Chiantia, ., P. Schwille. 2007. Pore formation
by a Bax-derived peptide: effect on the line tension of the membrane
probed by AFM. Biophys. J. 93:103–112.
31. Garcı´a-Sa´ez, A. J., M. Coraiola,., J. Salgado. 2005. Peptides derived
from apoptotic Bax and Bid reproduce the poration activity of the
parent full-length proteins. Biophys. J. 88:3976–3990.
32. Rzepiela, A. J., D. Sengupta,., S. J. Marrink. 2010. Membrane pora-
tion by antimicrobial peptides combining atomistic and coarse-grained
descriptions. Faraday Discuss. 144:431–443, discussion 445–481.
33. Qian, S., W. Wang, ., H. W. Huang. 2008. Structure of transmem-
brane pore induced by Bax-derived peptide: evidence for lipidic pores.
Proc. Natl. Acad. Sci. USA. 105:17379–17383.
34. Fuertes, G., D. Gime´nez, ., J. Salgado. 2011. A lipocentric view of
peptide-induced pores. Eur. Biophys. J. 40:399–415.
35. Esteban-Martı´n, S., H. J. Risselada,., S. J. Marrink. 2009. Stability of
asymmetric lipid bilayers assessed by molecular dynamics simulations.
J. Am. Chem. Soc. 131:15194–15202.
36. Tamba, Y., H. Ariyama, ., M. Yamazaki. 2010. Kinetic pathway of
antimicrobial peptide magainin 2-induced pore formation in lipid
membranes. J. Phys. Chem. B. 114:12018–12026.
37. Ludtke, S., K. He, and H. Huang. 1995. Membrane thinning caused by
magainin 2. Biochemistry. 34:16764–16769.
38. Chen, F. Y., M. T. Lee, and H.W. Huang. 2003. Evidence for membrane
thinning effect as the mechanism for peptide-induced pore formation.
Biophys. J. 84:3751–3758.
39. Gauthier, N. C., M. A. Fardin, ., M. P. Sheetz. 2011. Temporary
increase in plasma membrane tension coordinates the activation of
exocytosis and contraction during cell spreading. Proc. Natl. Acad.
Sci. USA. 108:14467–14472.
40. Vander Heiden, M. G., X. X. Li, ., M. Colombini. 2001. Bcl-xL
promotes the open configuration of the voltage-dependent anion
channel and metabolite passage through the outer mitochondrial
membrane. J. Biol. Chem. 276:19414–19419.
41. White, C., C. Li, ., J. K. Foskett. 2005. The endoplasmic reticulum
gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat.
Cell Biol. 7:1021–1028.
42. Maiuri, M. C., G. Le Toumelin,., G. Kroemer. 2007. Functional and
physical interaction between Bcl-X(L) and a BH3-like domain in Be-
clin-1. EMBO J. 26:2527–2539.
43. Karbowski, M., Y. J. Lee,., R. J. Youle. 2002. Spatial and temporal
association of Bax with mitochondrial fission sites, Drp1, and Mfn2
during apoptosis. J. Cell Biol. 159:931–938.
44. Montessuit, S., S. P. Somasekharan, ., J. C. Martinou. 2010.
Membrane remodeling induced by the dynamin-related protein Drp1
stimulates Bax oligomerization. Cell. 142:889–901.Biophysical Journal 104(2) 421–431
